Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY) -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (1184)	9/22/1999 11:03:00 PM
From: RCMac	Read Replies (1) \| Respond to of 3202

"Can Incyte Bounce Back? Incyte lost a round to Affymetrix in their battle over microarray patent rights. Is it a setback or death knell?" Article by Karl Thiel on Biospace: biospace.com Includes some discussion on the place of gene chips in INCY's overall business model. * * * * And an article from the UK newspaper The Guardian, "Blair and Clinton push to stop gene patents" newsunlimited.co.uk "Tony Blair and Bill Clinton are negotiating an Anglo-American agreement to protect the 100,000 genes that control the human body and provide the catalysts for medical advance. "The extraordinary deal - initiated by Mr Blair - aims to prevent entrepreneurs profiting from gene patents and to ensure that the benefits of research are freely available worldwide to combat or even eliminate diseases. The two leaders decided to act after an acceleration in the pace of discovery of the make-up of the human body. In 1997, 8,000 genes had been mapped; by 2003, the body's entire 100,000 genes will have been mapped. "The deal aims to ensure that world's largest medical charity, the British-owned Wellcome Trust, and the US government owned National Institute of Health, publicise genes within 24 hours of their discovery - so that the benefits accrue entirely to the public. Research bodies, universities or laboratories, would be obliged to waive their rights to patent their work in the public interest. " [snip]